March 2013 Br J Cardiol 2013;20:5 doi:10.5837/bjc.2013.003
Much has happened in cardiovascular medicine since the early 1990s. Deaths from coronary heart disease have more than halved during this period. We have seen the introduction of drug-eluting coronary stents, implantable cardioverter defibrillators (ICDs), cardiac resynchronisation therapy (CRT), ventricular assist devices and a host of new pharmacological treatments, many of which are disease modifying. The more recent national implementation of primary percutaneous coronary intervention (PPCI) will continue to help improve outcomes. Groundbreaking innovations such as the National Service Frameworks (NSF) have contributed to the dramatic dec
November 2003 Br J Cardiol 2003;10:411
Kim Fox, Henry Purcell, Philip Poole-Wilson
No content available
July 2002 Br J Cardiol 2002;9:377
Bryan Williams
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits